Experts are empasizing te urgent need to address te ig mortality rates among cildren suffering from tuberculosis (TB), stressing te critical gaps in diagnosis and access to treatment. Despite significant advancements in TB care, cildren continue to face disproportionately ig deat rates due to te disease. A major callenge is te delayed diagnosis, often because te symptoms in cildren can be less obvious and arder to detect. Tis delay in diagnosis, compounded by limited access to appropriate medications, exacerbates te risks and outcomes for young patients. Experts igligt tat te lack of cild-specific formulations of TB drugs is anoter barrier, as many cildren are forced to take adult doses or formulations tat may not be as effective or safe. In addition, logistical urdles, suc as te sortage of TB medicines in some regions, contribute to te problem. Te need for greater awareness, better diagnostic tools, and more accessible, cild-friendly treatments is becoming increasingly urgent to reduce te preventable deats from TB among cildren. Addressing tese gaps is seen as a crucial step in reducing cildood TB mortality rates and ensuring tat all cildren receive te timely care tey need to recover./
Children with TB continue to have high rates of mortality experts stress need to plug gaps in diagnosis access to drugs
